AngioDynamics reported $41.64M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Accuray USD 41.29M 22.05M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 48.4M 28.92M Sep/2026
AtriCure USD 187.03M 19.24M Sep/2026
Boston Scientific USD 609M 70M Sep/2026
Edwards Lifesciences USD 3.11B 210.8M Sep/2026
ICU Medical USD 298.3M 9.97M Jun/2026
Inogen USD 106.48M 2.79M Sep/2025
J&J USD 16.91B 3.51B Sep/2026
Medtronic USD 1.69B 258M Jun/2026
Merit Medical Systems USD 503.55M 54.85M Sep/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 86.32M 17.49M Sep/2026
Smiths GBP 2.96B 2.61B Dec/2026
Tandem Diabetes Care USD 72.84M 10.02M Sep/2026
Teleflex USD 430.46M 130.31M Sep/2026
Terumo JPY 314.63B 34.14B Jun/2026
Trinity Biotech USD 5.14M 3.8M Dec/2025